BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33765749)

  • 1. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
    Rageh RM; Hewedy ES; Hegab DS
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
    Nofal A; El-Arab RE; Nasr M; Alakad R
    J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
    Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
    Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Intralesional
    Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
    J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
    Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
    Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
    Vania R; Pranata R; Tan ST
    J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
    Eldahshan RM; Ashry WMO; Elsaie ML
    J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
    Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
    J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A; Nofal E; Yosef A; Nofal H
    Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts.
    Shaldoum DR; Hassan GFR; El Maadawy EH; El-Maghraby GM
    J Cosmet Dermatol; 2020 Aug; 19(8):2033-2040. PubMed ID: 31925891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
    Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
    Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
    Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
    J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
    Nofal A; Alakad R; Fouda I; Fawzy MM
    J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
    Singh AK; Devi KN; Bist JS
    Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional injection of measles, mumps, and rubella vaccine versus cryotherapy in treatment of warts: A randomized controlled trial.
    Abd El-Magiud EM; Abd El-Samea GM; Gaber HD
    Dermatol Ther; 2020 Mar; 33(2):e13257. PubMed ID: 32031726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
    Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
    Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
    Fawzy MM; Nofal A; Alakad R
    Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.
    Al-Qassabi AM; Al-Farsi F
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):413-416. PubMed ID: 36072081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
    Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
    Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.